HEADER OXIDOREDUCTASE 12-FEB-97 2GRT TITLE HUMAN GLUTATHIONE REDUCTASE A34E, R37W MUTANT, OXIDIZED GLUTATHIONE TITLE 2 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTATHIONE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GRTR; COMPND 5 EC: 1.6.4.2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: CONTAINS A NON-COVALENTLY BOUND FAD AND OXIDIZED COMPND 9 GLUTATHIONE SUBSTRATE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: BLOOD; SOURCE 6 CELL: RED BLOOD CELLS; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PUB302 KEYWDS OXIDOREDUCTASE, FLAVOENZYME EXPDTA X-RAY DIFFRACTION AUTHOR V.S.STOLL,S.J.SIMPSON,R.L.KRAUTH-SIEGEL,C.T.WALSH,E.F.PAI REVDAT 7 30-OCT-24 2GRT 1 REMARK REVDAT 6 15-NOV-23 2GRT 1 REMARK REVDAT 5 09-AUG-23 2GRT 1 REMARK REVDAT 4 03-NOV-21 2GRT 1 REMARK SEQADV REVDAT 3 13-JUL-11 2GRT 1 VERSN REVDAT 2 24-FEB-09 2GRT 1 VERSN REVDAT 1 12-AUG-97 2GRT 0 JRNL AUTH V.S.STOLL,S.J.SIMPSON,R.L.KRAUTH-SIEGEL,C.T.WALSH,E.F.PAI JRNL TITL GLUTATHIONE REDUCTASE TURNED INTO TRYPANOTHIONE REDUCTASE: JRNL TITL 2 STRUCTURAL ANALYSIS OF AN ENGINEERED CHANGE IN SUBSTRATE JRNL TITL 3 SPECIFICITY. JRNL REF BIOCHEMISTRY V. 36 6437 1997 JRNL REFN ISSN 0006-2960 JRNL PMID 9174360 JRNL DOI 10.1021/BI963074P REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.BRADLEY,U.S.BUCHELER,C.T.WALSH REMARK 1 TITL REDOX ENZYME ENGINEERING: CONVERSION OF HUMAN GLUTATHIONE REMARK 1 TITL 2 REDUCTASE INTO A TRYPANOTHIONE REDUCTASE REMARK 1 REF BIOCHEMISTRY V. 30 6124 1991 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH P.A.KARPLUS,G.E.SCHULZ REMARK 1 TITL REFINED STRUCTURE OF GLUTATHIONE REDUCTASE AT 1.54 A REMARK 1 TITL 2 RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 195 701 1987 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 3 REMARK 1 AUTH E.F.PAI,G.E.SCHULZ REMARK 1 TITL THE CATALYTIC MECHANISM OF GLUTATHIONE REDUCTASE AS DERIVED REMARK 1 TITL 2 FROM X-RAY DIFFRACTION ANALYSES OF REACTION INTERMEDIATES REMARK 1 REF J.BIOL.CHEM. V. 258 1752 1983 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 4 REMARK 1 AUTH R.K.WIERENGA,J.DRENTH,G.E.SCHULZ REMARK 1 TITL COMPARISON OF THE THREE-DIMENSIONAL PROTEIN AND NUCLEOTIDE REMARK 1 TITL 2 STRUCTURE OF THE FAD-BINDING DOMAIN OF P-HYDROXYBENZOATE REMARK 1 TITL 3 HYDROXYLASE WITH THE FAD-AS WELL AS NADPH-BINDING DOMAINS OF REMARK 1 TITL 4 GLUTATHIONE REDUCTASE REMARK 1 REF J.MOL.BIOL. V. 167 725 1983 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 5 REMARK 1 AUTH R.L.KRAUTH-SIEGEL,R.BLATTERSPIEL,M.SALEH,E.SCHILTZ, REMARK 1 AUTH 2 R.H.SCHIRMER,R.UNTUCHT-GRAU REMARK 1 TITL GLUTATHIONE REDUCTASE FROM HUMAN ERYTHROCYTES. THE SEQUENCES REMARK 1 TITL 2 OF THE NADPH DOMAIN AND OF THE INTERFACE DOMAIN REMARK 1 REF EUR.J.BIOCHEM. V. 121 259 1982 REMARK 1 REFN ISSN 0014-2956 REMARK 1 REFERENCE 6 REMARK 1 AUTH G.E.SCHULZ,R.H.SCHIRMER,E.F.PAI REMARK 1 TITL FAD-BINDING SITE OF GLUTATHIONE REDUCTASE REMARK 1 REF J.MOL.BIOL. V. 160 287 1982 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 7 REMARK 1 AUTH R.THIEME,E.F.PAI,R.H.SCHIRMER,G.E.SCHULZ REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF GLUTATHIONE REDUCTASE AT 2 A REMARK 1 TITL 2 RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 152 763 1981 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 8 REMARK 1 AUTH G.E.SCHULZ REMARK 1 TITL GENE DUPLICATION IN GLUTATHIONE REDUCTASE REMARK 1 REF J.MOL.BIOL. V. 138 335 1980 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 9 REMARK 1 AUTH R.UNTUCHT-GRAU,G.E.SCHULZ,R.H.SCHIRMER REMARK 1 TITL THE C-TERMINAL FRAGMENT OF HUMAN GLUTATHIONE REDUCTASE REMARK 1 TITL 2 CONTAINS THE POSTULATED CATALYTIC HISTIDINE REMARK 1 REF FEBS LETT. V. 105 244 1979 REMARK 1 REFN ISSN 0014-5793 REMARK 1 REFERENCE 10 REMARK 1 AUTH G.E.SCHULZ,R.H.SCHIRMER,W.SACHSENHEIMER,E.F.PAI REMARK 1 TITL THE STRUCTURE OF THE FLAVOENZYME GLUTATHIONE REDUCTASE REMARK 1 REF NATURE V. 273 120 1978 REMARK 1 REFN ISSN 0028-0836 REMARK 1 REFERENCE 11 REMARK 1 AUTH H.A.ZAPPE,G.KROHNE-EHRICH,G.E.SCHULZ REMARK 1 TITL LOW RESOLUTION STRUCTURE OF HUMAN ERYTHROCYTE GLUTATHIONE REMARK 1 TITL 2 REDUCTASE REMARK 1 REF J.MOL.BIOL. V. 113 141 1977 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 12 REMARK 1 AUTH G.E.SCHULZ,H.ZAPPE,D.J.WORTHINGTON,M.A.ROSEMEYER REMARK 1 TITL CRYSTALS OF HUMAN ERYTHROCYTE GLUTATHIONE REDUCTASE REMARK 1 REF FEBS LETT. V. 54 86 1975 REMARK 1 REFN ISSN 0014-5793 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.100 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 79.9 REMARK 3 NUMBER OF REFLECTIONS : 12177 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.82 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 44.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 812 REMARK 3 BIN R VALUE (WORKING SET) : 0.2590 REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3506 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 93 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : 10.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.780 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.13 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.760 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : FN3.PARM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPH19.PEP REMARK 3 TOPOLOGY FILE 3 : GR.TOP REMARK 3 TOPOLOGY FILE 4 : FN3.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2GRT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000178150. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : APR-93 REMARK 200 TEMPERATURE (KELVIN) : 287 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14065 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.100 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.7 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.11700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.82 REMARK 200 COMPLETENESS FOR SHELL (%) : 44.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIRECT BASED ON KNOWN REMARK 200 MODEL REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: PDB ENTRY 1GRT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.57-0.90 M AMMONIUM SULFATE, 100 MM REMARK 280 POTASSIUM PHOSPHATE, PH 8.0, AND 0.5% 1-N-BETA-OCTYL-D- REMARK 280 GLUCOPYRANOSIDE HANGING DROP VAPOR DIFFUSION. CRYSTALS WERE REMARK 280 SOAKED IN ARTIFICIAL MOTHER LIQUOR AT PH 6.5 420, VAPOR REMARK 280 DIFFUSION - HANGING DROP, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: B 1 1 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 X+1/2,Y,Z+1/2 REMARK 290 4555 -X+1/2,-Y,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 59.70000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 31.73000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 59.70000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 31.73000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 12010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 35110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -69.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 163.30234 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 72.23507 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 52 -138.46 -128.65 REMARK 500 VAL A 61 42.28 -148.20 REMARK 500 LYS A 93 81.21 101.40 REMARK 500 SER A 143 64.12 36.00 REMARK 500 ALA A 155 52.24 -115.21 REMARK 500 HIS A 219 -159.48 -123.15 REMARK 500 ASN A 240 -5.72 -59.75 REMARK 500 ALA A 288 51.23 -112.39 REMARK 500 ASP A 316 -163.17 -102.80 REMARK 500 LEU A 337 77.46 -67.64 REMARK 500 LYS A 416 -162.47 -105.26 REMARK 500 ASN A 425 -170.94 60.26 REMARK 500 GLU A 428 48.78 71.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: S1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: THE ACTIVE SITE HISTIDINE (HIS 467) IS FROM THE REMARK 800 OTHER SUBUNIT. REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 479 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GDS A 481 DBREF 2GRT A 18 478 UNP P00390 GSHR_HUMAN 18 478 SEQADV 2GRT GLU A 34 UNP P00390 ALA 34 ENGINEERED MUTATION SEQADV 2GRT TRP A 37 UNP P00390 ARG 37 ENGINEERED MUTATION SEQRES 1 A 461 VAL ALA SER TYR ASP TYR LEU VAL ILE GLY GLY GLY SER SEQRES 2 A 461 GLY GLY LEU GLU SER ALA TRP ARG ALA ALA GLU LEU GLY SEQRES 3 A 461 ALA ARG ALA ALA VAL VAL GLU SER HIS LYS LEU GLY GLY SEQRES 4 A 461 THR CYS VAL ASN VAL GLY CYS VAL PRO LYS LYS VAL MET SEQRES 5 A 461 TRP ASN THR ALA VAL HIS SER GLU PHE MET HIS ASP HIS SEQRES 6 A 461 ALA ASP TYR GLY PHE PRO SER CYS GLU GLY LYS PHE ASN SEQRES 7 A 461 TRP ARG VAL ILE LYS GLU LYS ARG ASP ALA TYR VAL SER SEQRES 8 A 461 ARG LEU ASN ALA ILE TYR GLN ASN ASN LEU THR LYS SER SEQRES 9 A 461 HIS ILE GLU ILE ILE ARG GLY HIS ALA ALA PHE THR SER SEQRES 10 A 461 ASP PRO LYS PRO THR ILE GLU VAL SER GLY LYS LYS TYR SEQRES 11 A 461 THR ALA PRO HIS ILE LEU ILE ALA THR GLY GLY MET PRO SEQRES 12 A 461 SER THR PRO HIS GLU SER GLN ILE PRO GLY ALA SER LEU SEQRES 13 A 461 GLY ILE THR SER ASP GLY PHE PHE GLN LEU GLU GLU LEU SEQRES 14 A 461 PRO GLY ARG SER VAL ILE VAL GLY ALA GLY TYR ILE ALA SEQRES 15 A 461 VAL GLU MET ALA GLY ILE LEU SER ALA LEU GLY SER LYS SEQRES 16 A 461 THR SER LEU MET ILE ARG HIS ASP LYS VAL LEU ARG SER SEQRES 17 A 461 PHE ASP SER MET ILE SER THR ASN CYS THR GLU GLU LEU SEQRES 18 A 461 GLU ASN ALA GLY VAL GLU VAL LEU LYS PHE SER GLN VAL SEQRES 19 A 461 LYS GLU VAL LYS LYS THR LEU SER GLY LEU GLU VAL SER SEQRES 20 A 461 MET VAL THR ALA VAL PRO GLY ARG LEU PRO VAL MET THR SEQRES 21 A 461 MET ILE PRO ASP VAL ASP CYS LEU LEU TRP ALA ILE GLY SEQRES 22 A 461 ARG VAL PRO ASN THR LYS ASP LEU SER LEU ASN LYS LEU SEQRES 23 A 461 GLY ILE GLN THR ASP ASP LYS GLY HIS ILE ILE VAL ASP SEQRES 24 A 461 GLU PHE GLN ASN THR ASN VAL LYS GLY ILE TYR ALA VAL SEQRES 25 A 461 GLY ASP VAL CYS GLY LYS ALA LEU LEU THR PRO VAL ALA SEQRES 26 A 461 ILE ALA ALA GLY ARG LYS LEU ALA HIS ARG LEU PHE GLU SEQRES 27 A 461 TYR LYS GLU ASP SER LYS LEU ASP TYR ASN ASN ILE PRO SEQRES 28 A 461 THR VAL VAL PHE SER HIS PRO PRO ILE GLY THR VAL GLY SEQRES 29 A 461 LEU THR GLU ASP GLU ALA ILE HIS LYS TYR GLY ILE GLU SEQRES 30 A 461 ASN VAL LYS THR TYR SER THR SER PHE THR PRO MET TYR SEQRES 31 A 461 HIS ALA VAL THR LYS ARG LYS THR LYS CYS VAL MET LYS SEQRES 32 A 461 MET VAL CYS ALA ASN LYS GLU GLU LYS VAL VAL GLY ILE SEQRES 33 A 461 HIS MET GLN GLY LEU GLY CYS ASP GLU MET LEU GLN GLY SEQRES 34 A 461 PHE ALA VAL ALA VAL LYS MET GLY ALA THR LYS ALA ASP SEQRES 35 A 461 PHE ASP ASN THR VAL ALA ILE HIS PRO THR SER SER GLU SEQRES 36 A 461 GLU LEU VAL THR LEU ARG HET FAD A 479 53 HET GDS A 481 40 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM GDS OXIDIZED GLUTATHIONE DISULFIDE FORMUL 2 FAD C27 H33 N9 O15 P2 FORMUL 3 GDS C20 H32 N6 O12 S2 HELIX 1 H1 GLY A 29 GLY A 43 1 15 HELIX 2 H2 GLY A 56 GLY A 86 1 31 HELIX 3 H3 TRP A 96 HIS A 122 1 27 HELIX 4 H4 GLY A 170 GLY A 174 5 5 HELIX 5 H5 SER A 177 LEU A 183 5 7 HELIX 6 H6 GLY A 196 LEU A 209 1 14 HELIX 7 H7 ASP A 227 GLY A 242 1 16 HELIX 8 H8 SER A 299 GLY A 304 5 6 HELIX 9 H9 GLY A 330 GLY A 334 5 5 HELIX 10 H10 LEU A 338 PHE A 354 1 17 HELIX 11 H11 THR A 383 GLY A 392 1 10 HELIX 12 H12 PRO A 405 ALA A 409 5 5 HELIX 13 H13 LEU A 444 MET A 453 1 10 HELIX 14 H14 THR A 456 ASN A 462 1 7 HELIX 15 H15 SER A 470 THR A 476 5 7 SHEET 1 A 8 GLU A 124 GLY A 128 0 SHEET 2 A 8 ARG A 45 GLU A 50 1 SHEET 3 A 8 ASP A 22 GLY A 27 1 SHEET 4 A 8 HIS A 151 ALA A 155 1 SHEET 5 A 8 GLY A 325 VAL A 329 1 SHEET 6 A 8 GLN A 319 VAL A 323 -1 SHEET 7 A 8 GLY A 311 ILE A 314 -1 SHEET 8 A 8 GLN A 306 ASP A 308 -1 SHEET 1 B 4 ALA A 19 TYR A 21 0 SHEET 2 B 4 LYS A 145 THR A 148 1 SHEET 3 B 4 THR A 139 VAL A 142 -1 SHEET 4 B 4 ALA A 131 THR A 133 -1 SHEET 1 C 5 ILE A 175 ILE A 175 0 SHEET 2 C 5 ASP A 283 ALA A 288 1 SHEET 3 C 5 GLY A 188 GLY A 194 1 SHEET 4 C 5 LYS A 212 ILE A 217 1 SHEET 5 C 5 GLU A 244 SER A 249 1 SHEET 1 D 4 PRO A 169 PRO A 169 0 SHEET 2 D 4 PHE A 248 THR A 257 1 SHEET 3 D 4 GLY A 260 ALA A 268 -1 SHEET 4 D 4 VAL A 275 VAL A 282 -1 SHEET 1 E 5 THR A 369 VAL A 371 0 SHEET 2 E 5 PRO A 376 LEU A 382 -1 SHEET 3 E 5 GLU A 428 GLY A 437 -1 SHEET 4 E 5 CYS A 417 ASN A 425 -1 SHEET 5 E 5 ASN A 395 PHE A 403 -1 SHEET 1 F 2 GLY A 157 SER A 161 0 SHEET 2 F 2 GLY A 290 ASN A 294 -1 SSBOND 1 CYS A 58 CYS A 63 1555 1555 2.25 SSBOND 2 CYS A 90 CYS A 90 1555 2665 2.73 CISPEP 1 HIS A 374 PRO A 375 0 0.19 CISPEP 2 HIS A 467 PRO A 468 0 0.43 SITE 1 S1 1 HIS A 467 SITE 1 AC1 33 ILE A 26 GLY A 27 GLY A 29 SER A 30 SITE 2 AC1 33 GLY A 31 GLU A 50 SER A 51 HIS A 52 SITE 3 AC1 33 LYS A 53 GLY A 56 THR A 57 CYS A 58 SITE 4 AC1 33 VAL A 61 GLY A 62 CYS A 63 LYS A 66 SITE 5 AC1 33 GLY A 128 HIS A 129 ALA A 130 ALA A 155 SITE 6 AC1 33 THR A 156 GLY A 157 TYR A 197 ARG A 291 SITE 7 AC1 33 GLY A 330 ASP A 331 LEU A 337 LEU A 338 SITE 8 AC1 33 THR A 339 PRO A 340 ALA A 342 HIS A 467 SITE 9 AC1 33 PRO A 468 SITE 1 AC2 18 SER A 30 GLU A 34 TRP A 37 VAL A 59 SITE 2 AC2 18 VAL A 64 TYR A 106 LEU A 110 ILE A 113 SITE 3 AC2 18 TYR A 114 ASN A 117 ILE A 343 PHE A 403 SITE 4 AC2 18 MET A 406 HIS A 467 THR A 469 GLU A 472 SITE 5 AC2 18 GLU A 473 THR A 476 CRYST1 119.400 84.530 63.460 90.00 90.00 58.71 B 1 1 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008375 -0.005090 0.000000 0.00000 SCALE2 0.000000 0.013844 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015758 0.00000